Open access
Aug 2026
Empagliflozin attenuates AGE-BSA/high-glucose-induced inflammation in C2C12 myotubes associated with suppression of the RAGE/NF-κB pathway
Empagliflozin attenuates AGE-BSA/high-glucose-induced inflammatory injury in C2C12 myotubes, and this effect is associated with reduced activation of RAGE/NF-κB-related inflammatory signaling.
Xiao-Ying Zhang, Yu Mao, Jia-Xing Wu et al.
· Frontiers in Endocrinology · 0 citations